On April 10, 2026, the Canada Revenue Agency (CRA) added an addendum to its Guidance on the Common Reporting Standard (CRS) stating that it is reverting paragraph 3.32 to its previous wording “for this reporting period,” with further revisions possible.
On December 19, 2025, the CRA revised paragraph 3.32 of its Guidance on the CRS. The revised wording stated that a partnership would be considered a Canadian resident partnership if all partners (including all end members) are resident in Canada, the place of effective management and control of the partnership’s business is situated in Canada, or the partnership was formed under the laws of a province or territory. That revision materially broadened the circumstances in which a partnership could be treated as resident in Canada for Part XIX purposes.
On April 10, 2026, the CRA published an addendum reversing course for now. The official addendum states that the CRA is “reverting to the previous wording for paragraph 3.32 for this reporting period” and that the paragraph “is currently being reviewed and may be revised at a later date.” Under the reverted wording, a partnership is considered resident in Canada under Part XIX if the place of effective management of the partnership’s business is situated in Canada.
The April 10 addendum effectively restores the pre-December status quo for the current reporting cycle. In practical terms, Canadian formed partnership or Canadian-resident partners, standing alone, do not currently determine whether a partnership is resident in Canada for CRS purposes; the operative test is again the place of effective management of the partnership’s business.
This is especially significant for cross-border fund structures that use Canadian partnerships but are managed outside Canada. Partnerships formed in Canada but managed from the United States or elsewhere will generally not be treated as Canadian resident partnerships solely because they were formed in Canada or because of partner residency; the analysis returns to where effective management is situated in practice. That point is also consistent with commentary noting that many foreign fund managers use Canadian-formed partnerships to facilitate investments and that the April 10 change is relieving for that reporting period.
The CRA’s addendum says the reversion applies “for this reporting period.” This means that certain partnerships may no longer be subject to CRS due diligence and reporting obligations in Canada for the 2025 reporting year, due before May 1, 2026. If a partnership was classified as a Canadian resident partnership solely because of the December 19 wording, its status should now be revisited under the restored place-of-effective-management test.
Should the CRA provide future updates to paragraph 3.32, measures such as a prospective effective date, appropriate grandfathering for pre existing structures, or a phased implementation period could support a smooth transition for investment fund and private equity structures that have operated under the place of effective management standard. Coordination with the Part XVIII/FATCA framework would likewise promote consistency and reduce classification complexity across parallel reporting regimes.
This publication contains general information only and Deloitte is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified professional advisor. Deloitte shall not be responsible for any loss sustained by any person who relies on this publication alone.